Jim Fong

Corporate Officer/Principal presso CTI BIOPHARMA CORP.

62 anni

Health Technology

Consumer Services

Posizioni attive di Jim Fong

Società	Posizione	Inizio	Fine
CTI BIOPHARMA CORP.	Corporate Officer/Principal	01/01/2008	-
CTI BIOPHARMA CORP.	Direttore operativo	01/01/2017	-

Società	Posizione	Inizio	Fine
CV Therapeutics, Inc. CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases	Vendite & Marketing	-	-

University of California, Los Angeles

Undergraduate Degree

Distribuzione geografica

Stati Uniti

Posizioni

Chief Operating Officer	1
Corporate Officer/Principal	1
Undergraduate Degree	1

Settori

Health Technology	3
Consumer Services	2

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Aziende private	2
CTI BioPharma Corp. CTI BioPharma Corp. Pharmaceuticals: MajorHealth Technology CTI BioPharma Corp. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. It focuses on evaluating pacritinib, its sole product candidate currently in active development, for the treatment of adult patients with myelofibrosis. The company was founded by James A. Bianco, Jack W. Singer, and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA.	Health Technology
CV Therapeutics, Inc. CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases	Health Technology

Aziende private

Health Technology